Articles Referencing ENDP

Merck Enters into Strategic Deal - Analyst Blog

5/22/2013, 6:26 pm from Zacks.com in Investing, Business, Stocks

In an attempt to boost shareholders' value, Merck & Co. Inc. ( MRK ) - the N.J. based major drug manufacturer - entered into an agreement with The Goldman Sachs Group, Inc. ( GS ... Read >>

Setback for Endo Health on Opana ER - Analyst Blog

5/13/2013, 6:05 pm from Zacks.com in Investing, Business, Stocks

Endo Health Solutions Inc. ( ENDP ) recently suffered a setback with the US Food and Drug Administration (FDA) turning down its request to prevent the entry of generic versions of the... Read >>

Earnings Beat at Endo Health, Sales Slip - Analyst Blog

5/8/2013, 6:24 pm from Zacks.com in Investing, Business, Earnings, Stocks

Endo Health Solutions' ( ENDP ) first quarter 2013 earnings (excluding special items) of $1.09 per share beat the Zacks Consensus Estimate by a penny and increased 25% from the year-ago... Read >>

Company News for May 8, 2013 - Corporate Summary

5/8/2013, 10:26 am from Zacks.com in Investing, Business, Investing Ideas, Stocks

•   AECOM Technology Corp (NYSE: ACM ) reported second quarter earnings per share of $0.53, beating the Zacks Consensus Estimate of $0.51 •    Endo Health... Read >>

Back to Neutral on Endo Health - Analyst Blog

3/6/2013, 2:10 pm from Zacks.com in Investing, Business, Stocks

We are reverting to a Neutral recommendation on Endo Health Solutions ( ENDP ) from Underperform as we believe that the stock is fairly valued at current levels. Our target price is $32.00.... Read >>

Actavis Files ANDA for Endo Product - Analyst Blog

3/5/2013, 4:40 pm from Zacks.com in Investing, Business, Stocks

Actavis, Inc. ( ACT ) recently announced that it is looking to get its generic version of Endo Health Solutions Inc. 's ( ENDP ) Fortesta (testosterone gel 10mg/0.5g) approved in the... Read >>

Earnings Beat at Endo Health - Analyst Blog

3/4/2013, 8:30 am from Zacks.com in Investing, Business, Earnings, Stocks

Endo Health Solutions ' ( ENDP ) fourth-quarter 2012 earnings (excluding special items) of $1.62 per share beat the Zacks Consensus Estimate of $1.56 and increased 15.7% from the year-ago... Read >>

After-Hours Earnings Report for February 28, 2013 : CRM, GPS, UHS, TEG, NGD, WR, MDVN, ENDP, GXP, MDR, CPNO, SLXP

2/28/2013, 2:00 pm from NASDAQ.com News in News Headlines, Earnings

The following companies are expected to report earnings after hours on 02/28/2013. Visit our Earnings Calendar for a full list of expected earnings releases. Salesforce.com Inc ( CRM ) is... Read >>

After Hours Most Active for Feb 27, 2013 : F, GRPN, JCI, ABT, ABBV, JCP, GTAT, QQQ, BAC, TLAB, ENDP, ACWI

2/27/2013, 4:45 pm from NASDAQ.com News in News Headlines, After Hours Most Active

The NASDAQ 100 After Hours Indicator is down -1.06 to 2,740.2. The total After hours volume is currently 31,871,127 shares traded. The following are the most active stocks for the after... Read >>

Mid-Day Market Update: Markets Turn Red, Dillard's Tumble On Downbeat Results

2/25/2013, 12:35 pm from Benzinga in Investing, Commodities, Economy, International

Midway through trading Monday, the Dow traded down 0.33 percent to 13,954.03 while the NASDAQ fell 0.09 percent to 3,158.89. The S&P also fell, declining 0.33 percent to 1,510.58. ... Read >>

Stock Market News for February 19, 2013 - Market News

2/19/2013, 9:36 am from Zacks.com in Investing, US Markets

Benchmarks finished Friday's trading session slightly higher, following mixed economic numbers and speculation of weak sales from a major retail company. The S&P 500 maintained its... Read >>

Mid-Afternoon Market Update: RIMM Falls Further, Endo Health Rises on Exploration of a Sale

1/30/2013, 3:22 pm from Benzinga in Investing, Commodities, Economy, International

Toward the end of trading Wednesday, the Dow traded down 0.26 percent to 13,918.18 while the NASDAQ was down 0.23 to 3,146.18. The S&P also fell, decreasing 0.28 percent to 1,503.25. ... Read >>

Endo Inks Deal with Indian Company - Analyst Blog

1/29/2013, 6:45 pm from Zacks.com in Investing, Business, Stocks

In a bid to establish its presence in the highly sought after Indian market, US based Endo Health Solutions Inc. ( ENDP ) recently inked a deal with GVK Biosciences., Based in India, GVK... Read >>

Bearish MACD for Endo Health Solutions Inc. - Tale of the Tape

1/22/2013, 11:01 am from Zacks.com in Investing, Investing Ideas, Stocks

Endo Health Solutions Inc. 's ( ENDP ) MACD indicator has moved into bearish territory with a reading of -0.0773. The Zacks Rank # 5 ("Strong Sell") stock decreased more than... Read >>

Impax Launches Opana ER Generic - Analyst Blog

1/7/2013, 2:52 pm from Zacks.com in Investing, Business, Stocks

Global Pharmaceuticals, the generic division of Impax Laboratories, Inc. ( IPXL ), a specialty pharmaceutical company, recently started shipping its generic version of Endo Health... Read >>